Outcomes of Partial and Cervical Pulpotomy in Primary Teeth Using Chitosan and Its Hydrogel Form: A Clinical Study

Comparative Evaluation of Partial Pulpotomy versus Cervical Pulpotomy in Primary Teeth Using Chitosan and Chitosan Hydrogel Combination a Clinic Radiographic Study. - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/109081

Enrollment

Registered

2026-04-22

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K040- Pulpitis

Interventions

Intervention1: Partial Pulpotomy in Primary teeth: Clinal and Radiographic Evaluation of Partial Pulpotomy in Primary teeth using Chitosan and Chitosan-Hydrogel combination for 12 months Control Inter

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cooperative otherwise healthy pediatric patients aged 4-8 years 2. Teeth with recent pulp exposure without any H/O spontaneous pain 3. Restorable crown structure present 4. Presence of at least 2/3rd root length 5. Bright red hemorrhage from exposure sites that can be controlled easily 6. No interradicular bone loss and radiolucency

Exclusion criteria

Exclusion criteria: 1. Uncooperative patient 2. Medically compromised children 3. Teeth with clinical sign and symptoms of pulpal exposure with spontaneous pain 4. Primary teeth with root resorption more than 2/3rd of the root length 5. A non-restorable tooth 6. Teeth with radiographic sign and symptoms of pulp degeneration, pathologic mobility, swelling or/and fistula, external or internal resorption and calcification of pulp

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Chitosan and a combination of Chitosan plus Hydrogel medicaments used in partial and cervical pulpotomies of primary teeth.Timepoint: 3,6,9 and 12 months	—

Secondary

Measure	Time frame
To compare the efficacy of above medicaments interval in terms of their clinical and radiographic success.Timepoint: 3,6,9 and 12 months	—

Countries

India

Contacts

Public ContactShireen Fotedar

shireen.fotedar.7@gmail.com08219890583

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026